united therapeutics
united therapeutics

2024年2月21日—UnitedTherapeuticssaidonWednesdayithadfiledacasewiththeU.S.FoodandDrugAdministration,allegingthatdueprocedurewasnot ...,UnitedTherapeutics'(UTHR)fourth-quarter2023earningsandsalesbeatestimates.Tyvasosalescontinuetodrivethecompany'st...

UTHR PIPELINE

Ournext-generationtherapiesaredesignedtoaddresstheunmetneedsofpatientslivingwithconditionssuchasPAH,PH,andend-stageorgandisease.VISION.

** 本站引用參考文章部分資訊，基於少量部分引用原則，為了避免造成過多外部連結，保留參考來源資訊而不直接連結，也請見諒 **

United Therapeutics starts litigation with FDA over rival ...

2024年2月21日 — United Therapeutics said on Wednesday it had filed a case with the U.S. Food and Drug Administration, alleging that due procedure was not ...

United Therapeutics Corporation (UTHR) 股價、新聞

United Therapeutics' (UTHR) fourth-quarter 2023 earnings and sales beat estimates. Tyvaso sales continue to drive the company's top line.

United Therapeutics Corporation

United Therapeutics is a biotechnology company focused on creating unique products to address the medical needs of patients with chronic illnesses.

UTHR PIPELINE

Our next-generation therapies are designed to address the unmet needs of patients living with conditions such as PAH, PH, and end-stage organ disease. VISION.

United Therapeutics

United Therapeutics Corporation is an American publicly traded biotechnology company and public benefit corporation listed on the NASDAQ under the symbol UTHR.

United Therapeutics

Our purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies and technologies that expand the availability ...

UTHR Investor Resources

Investor Resources for Pharmaceutical and Biotech Investment at United Therapeutics Corporation.

UTHR

United Therapeutics Corporation · UTHR ; 聯合治療公司 · Nasdaq ; 1000 Spring St,Silver Spring,Maryland 20910,United States Of America · http://www.unither.com.

說明

unitedtherapeutics

2024年2月21日—UnitedTherapeuticssaidonWednesdayithadfiledacasewiththeU.S.FoodandDrugAdministration,allegingthatdueprocedurewasnot ...,UnitedTherapeutics'(UTHR)fourth-quarter2023earningsandsalesbeatestimates.Tyvasosalescontinuetodrivethecompany'stopline.,UnitedTherapeuticsisabiotechnologycompanyfocusedoncreatinguniqueproductstoaddressthemedicalneedsofpatientswithchronicillnesses.,Ournext-genera...

參考資訊如下